ATE347398T1 - Carboxy methyl beta-1,3 glucan enthaltende ophthalmische lösung - Google Patents

Carboxy methyl beta-1,3 glucan enthaltende ophthalmische lösung

Info

Publication number
ATE347398T1
ATE347398T1 AT02425379T AT02425379T ATE347398T1 AT E347398 T1 ATE347398 T1 AT E347398T1 AT 02425379 T AT02425379 T AT 02425379T AT 02425379 T AT02425379 T AT 02425379T AT E347398 T1 ATE347398 T1 AT E347398T1
Authority
AT
Austria
Prior art keywords
ophthalmic solution
carboxy methyl
containing ophthalmic
methyl beta
glucan containing
Prior art date
Application number
AT02425379T
Other languages
English (en)
Inventor
Luigi Mercuri
Original Assignee
Dmg Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmg Italia Srl filed Critical Dmg Italia Srl
Application granted granted Critical
Publication of ATE347398T1 publication Critical patent/ATE347398T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
AT02425379T 2002-06-10 2002-06-10 Carboxy methyl beta-1,3 glucan enthaltende ophthalmische lösung ATE347398T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02425379A EP1421974B1 (de) 2002-06-10 2002-06-10 Carboxy Methyl Beta-1,3 Glucan enthaltende ophthalmische Lösung

Publications (1)

Publication Number Publication Date
ATE347398T1 true ATE347398T1 (de) 2006-12-15

Family

ID=32187303

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02425379T ATE347398T1 (de) 2002-06-10 2002-06-10 Carboxy methyl beta-1,3 glucan enthaltende ophthalmische lösung

Country Status (5)

Country Link
EP (1) EP1421974B1 (de)
AT (1) ATE347398T1 (de)
DE (1) DE60216612T2 (de)
ES (1) ES2276906T3 (de)
PT (1) PT1421974E (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008010241A1 (en) * 2006-07-18 2008-01-24 D.M.G. Italia Srl A liposomal complex of sodium carboxymethyl beta-glucan
EP2229180A1 (de) * 2007-12-27 2010-09-22 D.M.G. Italia Srl Zusammensetzung mit superoxid-dismutase und carboxy-methyl-beta-1,3-glucan
ITRM20110105A1 (it) * 2011-03-03 2012-09-04 Sooft Italia Spa Composizione ed uso di collirio antiedemigeno a base di acido lattobionico

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946450A (en) * 1989-04-18 1990-08-07 Biosource Genetics Corporation Glucan/collagen therapeutic eye shields
GB9403153D0 (en) * 1994-02-18 1994-04-06 Ciba Geigy Ag Cosmetic compositions
DE59711933D1 (de) * 1996-07-19 2004-10-28 Mibelle Ag Cosmetics Polymere Glucanäther-Derivate, ihre Herstellung sowie ihre Verwendung
US6599879B1 (en) * 1998-02-13 2003-07-29 Human Genome Sciences, Inc. Therapeutic uses of keratinocyte growth factor-2
AU3747800A (en) * 1999-03-18 2000-10-04 Bausch & Lomb Incorporated Method for treating dry eye
IT1307281B1 (it) * 1999-11-25 2001-10-30 Simonelli Giuseppe Uso di ubichinone q10 per il trattamento locale e la prevenzione dipatalogie oftalmologiche secondarie alla terapia fotorefrattiva,

Also Published As

Publication number Publication date
PT1421974E (pt) 2007-03-30
EP1421974A1 (de) 2004-05-26
DE60216612D1 (de) 2007-01-18
EP1421974B1 (de) 2006-12-06
ES2276906T3 (es) 2007-07-01
DE60216612T2 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
EP1878725A3 (de) Pyrimidinderivate und deren Verwendung als CB2-Modulatoren
WO2002092026A3 (en) Dermatological and cosmetic compositions
EP1646614A4 (de) Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
BR0210205A (pt) Antiinfecciosos
IS2517B (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
ATE304358T1 (de) (s,s)-reboxetin zur behandlung von migränekopfschmerzen
TW200621745A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
EP2497478A3 (de) Oligosaccarid-Zusammensetzungen und ihre Verwendung bei der Behandlung von Infektionen
BR0010704A (pt) Composições e métodos de anti-náusea
WO2006004741A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
IL145068A0 (en) The use of glycine betaine to prepare a pharmaceutical composition
WO2006004684A8 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
BR0012696A (pt) Composição oftálmica
BRPI0508137A (pt) composição de tratamento dos cabelos, método de alisamento de cabelos e uso da composição
BRPI0411085A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de vìrus oncogênicos, e de condições ou distúrbios devidos a infecção por hpv
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
EP1736470A3 (de) Pyrimidin-Derivate als cb2 Cannabinoid-Rezeptor Modulatoren
AU2003273843A8 (en) Use of skin-protecting substances
NO20014240L (no) C16-umettede FP-selektive prostaglandinanaloger
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
ATE347398T1 (de) Carboxy methyl beta-1,3 glucan enthaltende ophthalmische lösung
EP1743623A3 (de) Verwendung von Harnstoffverbindungen zur Förderung der Desquamation
BRPI0411245A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de vìrus oncogênicos e para tratamento ou profilaxia de condições ou distúrbios devidos a infecção por hpv

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties